{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T14:50:20Z","timestamp":1782226220691,"version":"3.54.5"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2002,7,1]],"date-time":"2002-07-01T00:00:00Z","timestamp":1025481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,7,1]],"date-time":"2002-07-01T00:00:00Z","timestamp":1025481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2002,7,1]]},"DOI":"10.1038\/sj.bmt.1703609","type":"journal-article","created":{"date-parts":[[2002,9,3]],"date-time":"2002-09-03T18:27:21Z","timestamp":1031077641000},"page":"95-102","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Allogeneic hematopoietic stem cell transplantation in ovarian carcinoma: results of five patients"],"prefix":"10.1038","volume":"30","author":[{"given":"J-O","family":"Bay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Fleury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Choufi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Tournilhac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Bailly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Dauplat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Viens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Faucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Blaise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2002,7,22]]},"reference":[{"key":"BF1703609_CR1","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1002\/1097-0142(197212)30:6<1565::AID-CNCR2820300623>3.0.CO;2-H","volume":"30","author":"JP Smith","year":"1972","unstructured":"Smith JP, Rutledge F, Wharton JT . Chemotherapy in ovarian cancer. New approaches to treatment Cancer 1972 30: 1565 1571","journal-title":"Cancer"},{"key":"BF1703609_CR2","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1056\/NEJM197604152941605","volume":"294","author":"JS Tobias","year":"1976","unstructured":"Tobias JS, Griffiths CT . Management of ovarian carcinoma. Current concepts and future prospects New Engl J Med 1976 294: 881 882","journal-title":"New Engl J Med"},{"key":"BF1703609_CR3","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1093\/annonc\/4.suppl_4.S35","volume":"4","author":"JT Thigpen","year":"1993","unstructured":"Thigpen JT, Bertelsen K, Eisenhauer EA et al. Long-term follow-up of patients with advanced ovarian carcinoma treated with chemotherapy Ann Oncol 1993 4: (Suppl. 4) S35 S40","journal-title":"Ann Oncol"},{"key":"BF1703609_CR4","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/1097-0142(19950101)75:1+<270::AID-CNCR2820751312>3.0.CO;2-D","volume":"75","author":"CE Platz","year":"1995","unstructured":"Platz CE, Benda JA . Female genital tract cancer Cancer 1995 75: (Suppl. 1) 270 294","journal-title":"Cancer"},{"key":"BF1703609_CR5","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.1006\/gyno.1994.1347","volume":"55","author":"T Thigpen","year":"1994","unstructured":"Thigpen T, Vance R, Puneky L et al. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials Gynecol Oncol 1994 55: S97 S107","journal-title":"Gynecol Oncol"},{"key":"BF1703609_CR6","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1200\/JCO.1994.12.11.2301","volume":"12","author":"P Francis","year":"1994","unstructured":"Francis P, Schneider J, Hann L et al. Phase II trial of docetaxel in patients with platinum-refractory advanced ovarian cancer J Clin Oncol 1994 12: 2301 2308","journal-title":"J Clin Oncol"},{"key":"BF1703609_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJM199601043340101","volume":"334","author":"WP McGuire","year":"1996","unstructured":"McGuire WP, Hoskins WJ, Brady MF et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer New Engl J Med 1996 334: 1 6","journal-title":"New Engl J Med"},{"key":"BF1703609_CR8","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1200\/JCO.1997.15.4.1309","volume":"15","author":"PJ Stiff","year":"1997","unstructured":"Stiff PJ, Bayer R, Kerger C et al. High-dose chemotherapy with autologous transplantation for persistent\/relapsed ovarian cancer: a multivariate analysis of survival for 100 consecutively treated patients J Clin Oncol 1997 15: 1291 1293","journal-title":"J Clin Oncol"},{"key":"BF1703609_CR9","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1200\/JCO.1997.15.4.1302","volume":"15","author":"M Legros","year":"1997","unstructured":"Legros M, Dauplat J, Fleury J et al. High-dose chemotherapy with hematopoietic rescue in patients with stage III to IV ovarian cancer: long-term results J Clin Oncol 1997 15: 1302 1308","journal-title":"J Clin Oncol"},{"key":"BF1703609_CR10","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.1200\/JCO.1997.15.11.3399","volume":"15","author":"RP Edwards","year":"1997","unstructured":"Edwards RP, Gooding W, Lembersky BC et al. Comparison of toxicity and survival following intraperitoneal recombinant interleukin-2 for persistent ovarian cancer after platinum: 24-hour versus 7-day infusion J Clin Oncol 1997 15: 3399 3407","journal-title":"J Clin Oncol"},{"key":"BF1703609_CR11","first-page":"2268","volume":"6","author":"RS Freedman","year":"2000","unstructured":"Freedman RS, Kudelka AP, Kavanagh JJ et al. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma Clin Cancer Res 2000 6: 2268 2278","journal-title":"Clin Cancer Res"},{"key":"BF1703609_CR12","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1056\/NEJM197504242921706","volume":"292","author":"ED Thomas","year":"1975","unstructured":"Thomas ED, Strob R, Clift RA et al. Bone-marrow transplantation New Engl J Med 1975 292: 895 902","journal-title":"New Engl J Med"},{"key":"BF1703609_CR13","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1056\/NEJM197905103001902","volume":"300","author":"PL Weiden","year":"1979","unstructured":"Weiden PL, Flournoy N, Thomas ED et al. Anti-leukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts New Engl J Med 1979 300: 1068 1073","journal-title":"New Engl J Med"},{"key":"BF1703609_CR14","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1182\/blood.V84.4.1050.1050","volume":"84","author":"V Ratanatharathorn","year":"1994","unstructured":"Ratanatharathorn V, Uberti J, Karanes C et al. Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma Blood 1994 84: 1050 1055","journal-title":"Blood"},{"key":"BF1703609_CR15","first-page":"111","volume":"18","author":"NC Gorin","year":"1996","unstructured":"Gorin NC, Lebopin M, Fouillard L et al. Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia Bone Marrow Transplant 1996 18: 111 117","journal-title":"Bone Marrow Transplant"},{"key":"BF1703609_CR16","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1182\/blood.V73.6.1720.1720","volume":"73","author":"K Sullivan","year":"1989","unstructured":"Sullivan K, Weiden P, Storb R et al. Influence of chronic graft-versus-disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia Blood 1989 73: 1720 1728","journal-title":"Blood"},{"key":"BF1703609_CR17","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1056\/NEJM198106183042507","volume":"304","author":"P Weiden","year":"1981","unstructured":"Weiden P, Sullivan K, Flournoy N et al. Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation New Engl J Med 1981 304: 1529 1533","journal-title":"New Engl J Med"},{"key":"BF1703609_CR18","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","volume":"75","author":"MM Horowitz","year":"1990","unstructured":"Horowitz MM, Gale RP, Sondel PM et al. Graft-versus-leukemia reactions after bone marrow transplantation Blood 1990 75: 555 562","journal-title":"Blood"},{"key":"BF1703609_CR19","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0140-6736(87)90763-X","volume":"2","author":"D Maraninchi","year":"1987","unstructured":"Maraninchi D, Gluckman E, Blaise D et al. Impact of T-cell depletion on outcome of allogeneic bone-marrow transplantation for standard-risk leukaemias Lancet 1987 2: 175 178","journal-title":"Lancet"},{"key":"BF1703609_CR20","doi-asserted-by":"publisher","first-page":"806","DOI":"10.7326\/0003-4819-108-6-806","volume":"108","author":"J Goldman","year":"1988","unstructured":"Goldman J, Gale R, Horowitz M et al. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion Ann Intern Med 1988 108: 806 814","journal-title":"Ann Intern Med"},{"key":"BF1703609_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0140-6736(93)92526-Y","volume":"341","author":"D Blaise","year":"1993","unstructured":"Blaise D, Gravis G, Maraninchi D . Long-term follow-up of T-cell depletion for bone marrow transplantation Lancet 1993 341: 51 52","journal-title":"Lancet"},{"key":"BF1703609_CR22","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.V86.5.2041.bloodjournal8652041","volume":"86","author":"H Kolb","year":"1995","unstructured":"Kolb H, Schattenberg A, Goldman J et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients Blood 1995 86: 2041 2050","journal-title":"Blood"},{"key":"BF1703609_CR23","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1182\/blood.V89.12.4531","volume":"89","author":"S Giralt","year":"1997","unstructured":"Giralt S, Estey E, Albitar M et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy Blood 1997 89: 4531 4536","journal-title":"Blood"},{"key":"BF1703609_CR24","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","volume":"91","author":"S Slavin","year":"1998","unstructured":"Slavin S, Nagler A, Naparstek E et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases Blood 1998 91: 756 763","journal-title":"Blood"},{"key":"BF1703609_CR25","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1182\/blood.V94.9.3234","volume":"94","author":"R Childs","year":"1999","unstructured":"Childs R, Clave E, Contentin N et al. Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses Blood 1999 94: 3234 3241","journal-title":"Blood"},{"key":"BF1703609_CR26","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1046\/j.1365-2141.1999.01706.x","volume":"107","author":"R Childs","year":"1999","unstructured":"Childs R, Epperson D, Bahceci E et al. Molecular remission of chronic myeloid leukaemia following a non-myeloablative allogeneic peripheral blood stem cell transplant: in vivo and in vitro evidence for a graft-versus-leukaemia effect Br J Haematol 1999 107: 396 400","journal-title":"Br J Haematol"},{"key":"BF1703609_CR27","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/S0140-6736(05)65517-1","volume":"348","author":"R Ben-Yosef","year":"1996","unstructured":"Ben-Yosef R, Or R, Nagler A et al. Graft-versus-tumour and graft-versus-leukaemia effect in patient with concurrent breast cancer and acute myelocytic leukaemia Lancet 1996 348: 1242 1243","journal-title":"Lancet"},{"key":"BF1703609_CR28","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood.V88.4.1501.bloodjournal8841501","volume":"88","author":"B Eibl","year":"1996","unstructured":"Eibl B, Schwaighofer H, Nachbaur D et al. Evidence for a graft-versus-tumor effect in a patient treated with marrow ablative chemotherapy and allogeneic bone marrow transplantation for breast cancer Blood 1996 88: 1501 1508","journal-title":"Blood"},{"key":"BF1703609_CR29","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1200\/JCO.1998.16.3.986","volume":"16","author":"N Ueno","year":"1998","unstructured":"Ueno N, Rondon G, Mirza NQ et al. Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer J Clin Oncol 1998 16: 986 993","journal-title":"J Clin Oncol"},{"key":"BF1703609_CR30","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1056\/NEJM200009143431101","volume":"343","author":"R Childs","year":"2000","unstructured":"Childs R, Chernoff A, Contentin N et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation New Engl J Med 2000 343: 750 758","journal-title":"New Engl J Med"},{"key":"BF1703609_CR31","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/sj.bmt.1702206","volume":"25","author":"J-O Bay","year":"2000","unstructured":"Bay J-O, Choufi B, Pomel C et al. Potential allogeneic graft-versus-tumor effect in a patient with ovarian cancer Bone Marrow Transplant 2000 25: 681 682","journal-title":"Bone Marrow Transplant"},{"key":"BF1703609_CR32","first-page":"1","volume":"6","author":"HJ Deeg","year":"1990","unstructured":"Deeg HJ, Henslee-Downey PJ . Management of acute graft-versus-host disease Bone Marrow Transplant 1990 6: 1 8","journal-title":"Bone Marrow Transplant"},{"key":"BF1703609_CR33","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1097\/00007890-199511000-00010","volume":"60","author":"JY Cahn","year":"1995","unstructured":"Cahn JY, Bordigoni P, Tiberghien P et al. Treatment of acute graft-versus-host disease with methylprednisolone and cyclosporine with or without an anti-interleukin-2 receptor monoclonal antibody. A multicenter phase III study Transplantation 1995 60: 939 942","journal-title":"Transplantation"},{"key":"BF1703609_CR34","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors Transplantation 1974 18: 295 304","journal-title":"Transplantation"},{"key":"BF1703609_CR35","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1056\/NEJM199403243301206","volume":"330","author":"JO Armitage","year":"1994","unstructured":"Armitage JO . Bone marrow transplantation New Engl J Med 1994 330: 827 838","journal-title":"New Engl J Med"},{"key":"BF1703609_CR36","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1182\/blood.V84.2.380.380","volume":"84","author":"DR Rill","year":"1994","unstructured":"Rill DR, Santana VM, Roberts WM et al. Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells Blood 1994 84: 380 383","journal-title":"Blood"},{"key":"BF1703609_CR37","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1182\/blood.V94.7.2523.419k18_2523_2529","volume":"94","author":"R Storb","year":"1999","unstructured":"Storb R, Yu C, Zaucha JM et al. Stable mixed hematopoietic chimerism in dogs given donor antigen, CTLA4Ig, and 100 cGy total body irradiation before and pharmacologic immunosuppression after marrow transplant Blood 1999 94: 2523 2529","journal-title":"Blood"},{"key":"BF1703609_CR38","first-page":"78","volume":"2(Suppl. 5)","author":"BM Sandmaier","year":"2000","unstructured":"Sandmaier BM, McSweeney P, Yu C et al. Nonmyeloablative transplants: preclinical and clinical results Semin Oncol 2000 2(Suppl. 5): 78 81","journal-title":"Semin Oncol"},{"key":"BF1703609_CR39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/00001622-200101000-00006","volume":"13","author":"RD Dansey","year":"2001","unstructured":"Dansey RD, Baynes RD . Nonablative allogeneic hematopoietic stem cell transplantation Curr Opin Oncol 2001 13: 27 32","journal-title":"Curr Opin Oncol"},{"key":"BF1703609_CR40","doi-asserted-by":"publisher","first-page":"3340","DOI":"10.1200\/JCO.2001.19.14.3340","volume":"19","author":"M Michallet","year":"2001","unstructured":"Michallet M, Bilger K, Garban F et al. Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens: impact of pretransplantation and posttransplantation factors on outcome J Clin Oncol 2001 19: 3340 3349","journal-title":"J Clin Oncol"},{"key":"BF1703609_CR41","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/S0301-472X(00)00655-X","volume":"29","author":"A Nagler","year":"2001","unstructured":"Nagler A, Aker M, Or R et al. Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation Exp Hematol 2001 29: 362 370","journal-title":"Exp Hematol"},{"key":"BF1703609_CR42","first-page":"411","volume":"18","author":"LA Russell","year":"1996","unstructured":"Russell LA, Jacobsen N, Heilmann C et al. Treatment of relapse after allogeneic BMT with donor leukocyte infusions in 16 patients Bone Marrow Transplant 1996 18: 411 414","journal-title":"Bone Marrow Transplant"},{"key":"BF1703609_CR43","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/sj.leu.2400546","volume":"11","author":"H Bertz","year":"1997","unstructured":"Bertz H, Burger JA, Kunzmann R et al. Adoptive immunotherapy for relapsed multiple myeloma after allogeneic bone marrow transplantation (BMT): evidence for a graft-versus-myeloma effect Leukemia 1997 11: 281 283","journal-title":"Leukemia"},{"key":"BF1703609_CR44","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1182\/blood.V96.8.2712","volume":"96","author":"F Dazzi","year":"2000","unstructured":"Dazzi F, Szydlo RM, Cross N et al. Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia Blood 2000 96: 2712 2716","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1703609","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703609.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703609.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T23:19:35Z","timestamp":1648077575000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1703609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7,1]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,7,1]]}},"alternative-id":["BF1703609"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1703609","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,7,1]]},"assertion":[{"value":"30 October 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2002","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}